The CYP51s of Saccharomyces cerevisiae and Candida albicans exist as multiple isoforms and might influence the outcome of azole antifungal therapy.
Published in 2017 by
Patrick Van Dijck,
Anneke Kremer,
Saskia Lippens,
Inge Van Bogaert,
Michelle Holtappels,
Marilyn De Graeve,
Winnie Kerstens 
,
Alessandro Fiori
,
Alessandro Fiori
